Company Filing History:
3 out of 4,948 
2 out of 168 
1 out of 3,685 
Years Active: 2020-2024
Title: Anja Mølhart Høg: Innovator in Neurobiology
Introduction
Anja Mølhart Høg is a prominent inventor based in Hillerød, Denmark. He has made significant contributions to the field of neurobiology, particularly in the development of therapeutic methods for neurodegenerative diseases. With a total of six patents to his name, Høg's work focuses on innovative solutions for complex medical challenges.
Latest Patents
Høg's latest patents include groundbreaking inventions such as "Oligonucleotides for modulating Tau expression." This invention relates to antisense oligonucleotides that can modulate the expression of Tau in target cells. The oligonucleotides hybridize to MAPT mRNA, providing a potential treatment avenue for various Tauopathies, including Alzheimer's disease and fronto-temporal dementia. Another notable patent is related to "Methods of selecting therapeutic molecules," which outlines methods for identifying safe molecules for administration using calcium oscillation assays and sequence score calculations.
Career Highlights
Throughout his career, Anja Mølhart Høg has worked with esteemed companies such as Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research and treatment.
Collaborations
Høg has collaborated with notable colleagues, including Peter Hagedorn and Marianne Lerbech Jensen. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in neurobiology.
Conclusion
Anja Mølhart Høg is a distinguished inventor whose work in neurobiology has the potential to transform the treatment of neurodegenerative diseases. His patents reflect a commitment to advancing medical science and improving patient outcomes.